🇺🇸 FDA

Company profile · Sponsor

CUMBERLAND

CUMBERLAND PHARMACEUTICALS INC

CPIX · NYSE pharma NASHVILLE,, TN, USA
Pipeline
24
Drugs
2
Patents
8

Quick answer

CUMBERLAND (CPIX) is a pharma company. headquartered in NASHVILLE,, TN, USA. listed on NYSE. NovaPharmaNews links 24 pipeline programs, 2 drugs, and 8 patents to this profile..

Company facts

Ticker CPIX
Exchange NYSE
Company type pharma
Headquarters NASHVILLE,, TN, USA
SEC CIK 0001087294

Pipeline (24)

Search pipeline →

  1. Acetadote EF (Ethylenediaminetetraacetic Acid (EDTA) - Free)

    CUMBERLAND

    Acetaminophen Overdose

    phase 3 small molecule terminated

    1 trial

  2. Caldolor

    CUMBERLAND

    Burns

    phase 3 small molecule completed

    1 trial

  3. Caldolor

    CUMBERLAND

    Pain

    phase 3 small molecule completed

    1 trial

  4. Caldolor

    CUMBERLAND

    Fever

    phase 3 small molecule completed

    1 trial

  5. Conivaptan hydrochloride

    CUMBERLAND

    Hyponatremia

    phase 3 small molecule terminated

    1 trial

  6. Ibuprofen

    CUMBERLAND

    Fever

    phase 3 small molecule completed

    2 trials

  7. Intravenous Ibuprofen

    CUMBERLAND

    Postoperative Pain

    phase 3 small molecule active

    1 trial

  8. Intravenous ibuprofen

    CUMBERLAND

    Tonsillectomy

    phase 3 small molecule completed

    1 trial

  9. Telavancin

    CUMBERLAND

    Staphylococcal Skin Infection

    phase 3 small molecule completed

    2 trials

  10. Telavancin

    CUMBERLAND

    Bacteremia

    phase 3 small molecule terminated

    1 trial

  11. Telavancin

    CUMBERLAND

    Bacterial Pneumonia

    phase 3 small molecule completed

    2 trials

  12. YM087

    CUMBERLAND

    Hyponatremia

    phase 3 small molecule completed

    1 trial

  13. YM087 oral

    CUMBERLAND

    Hyponatremia

    phase 3 small molecule completed

    1 trial

  14. 90 grams of Crystalline Lactulose

    CUMBERLAND

    Colonoscopy Preparation

    phase 2 small molecule completed

    1 trial

  15. Atorvastatin injection

    CUMBERLAND

    Hypercholesterolemia

    phase 2 small molecule completed

    1 trial

  16. Crystalline Lactulose

    CUMBERLAND

    Colonoscopy

    phase 2 small molecule completed

    1 trial

  17. Full dose preparation

    CUMBERLAND

    Colonoscopy Preparation

    phase 2 small molecule completed

    1 trial

  18. Ifetroban

    CUMBERLAND

    Portal Hypertension

    phase 2 small molecule completed

    1 trial

  19. Ifetroban

    CUMBERLAND

    Duchenne Muscular Dystrophy Cardiomyopathy

    phase 2 small molecule completed

    1 trial

  20. Ifetroban Injection

    CUMBERLAND

    Hepatorenal Syndrome

    phase 2 small molecule completed

    1 trial

  21. Ifetroban Oral Capsule

    CUMBERLAND

    Asthma, Aspirin-Induced

    phase 2 small molecule completed

    1 trial

  22. Ifetroban Sodium

    CUMBERLAND

    Cardiovascular Diseases

    phase 2 small molecule completed

    1 trial

  23. Ifetroban Sodium

    CUMBERLAND

    Idiopathic Pulmonary Fibrosis

    phase 2 small molecule active

    1 trial

  24. Ifetroban Sodium

    CUMBERLAND

    Malignant Solid Tumor

    phase 2 small molecule active

    1 trial

Drugs (2)

Search drugs →

  1. conivaptan hydrochloride

    VAPRISOL

    INJECTION approved

  2. telavancin hydrochloride

    VIBATIV

    INTRAVENOUS approved

Patents (8)

Search patents →

  1. US 12161632

    Compositions and methods of treating cardiac fibrosis with ifetroban

    Expires Mon Dec 05 2044 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  2. US 11806400

    Injectable ibuprofen formulation

    Expires Mon Nov 02 2043 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  3. US 11571412

    Thromboxane receptor antagonists in AERD/asthma

    Expires Mon Feb 02 2043 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  4. US 10925860

    Compositions and methods of treating cardiac fibrosis with ifetroban

    Expires Mon Feb 18 2041 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  5. US 10751383

    Doses and methods for administering telavancin

    Expires Mon Aug 20 2040 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  6. US 10583126

    Compositions and methods of treating cardiac fibrosis with ifetroban

    Expires Mon Mar 05 2040 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  7. US 10456380

    Compositions and methods of treating muscular dystrophy with thromboxane-A2 receptor antagonists

    Expires Mon Oct 24 2039 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  8. US 10314824

    Compositions and methods of treating cardiac fibrosis with ifetroban

    Expires Mon Jun 06 2039 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

Frequently asked questions

What is CUMBERLAND?

CUMBERLAND (CPIX) is a pharma company. headquartered in NASHVILLE,, TN, USA. listed on NYSE. NovaPharmaNews links 24 pipeline programs, 2 drugs, and 8 patents to this profile..

What pipeline programs does CUMBERLAND sponsor?

We track 24 ClinicalTrials.gov-linked programs for CUMBERLAND, including Acetadote EF (Ethylenediaminetetraacetic Acid (EDTA) - Free) and 23 more. Open each program for phase, modality, NCT IDs, and indication details.

Where does CUMBERLAND company data come from?

Profiles combine SEC EDGAR (CIK/ticker), ClinicalTrials.gov sponsor links, FDA drug records, and USPTO patent metadata. See our data sources page. This profile is for professional reference, not investment advice.